RELAPSE/RECURRENCE

Clinical trials for RELAPSE/RECURRENCE explained in plain language.

Never miss a new study

Get alerted when new RELAPSE/RECURRENCE trials appear

Sign up with your email to follow new studies for RELAPSE/RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New hope for rare blood cancer patients: experimental drug combo shows promise in early trial

Disease control Ongoing

This study tests whether adding the experimental drug lacutamab to standard chemotherapy (GemOx) helps control peripheral T-cell lymphoma, a rare blood cancer, in people whose cancer has returned or stopped responding to prior treatments. About 49 adults with a specific marker (K…

Matched conditions: RELAPSE/RECURRENCE

Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control

Last updated Jun 18, 2026 11:46 UTC

RELAPSE/RECURRENCE

Get alerted when new RELAPSE/RECURRENCE trials appear

New hope for rare blood cancer patients: experimental drug combo shows promise in early trial